Financhill
Sell
50

TYOBY Quote, Financials, Valuation and Earnings

Last price:
$6.85
Seasonality move :
-4.68%
Day range:
$6.85 - $6.85
52-week range:
$6.54 - $7.20
Dividend yield:
0%
P/E ratio:
45.92x
P/S ratio:
0.22x
P/B ratio:
0.46x
Volume:
--
Avg. volume:
--
1-year change:
-4.86%
Market cap:
$604M
Revenue:
$2.8B
EPS (TTM):
$0.15
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3.2B $3.3B $3B $2.9B $2.8B
Revenue Growth (YoY) 1.86% 5.15% -11.51% -3.07% -3.49%
 
Cost of Revenues $2.3B $2.5B $2.3B $2.3B $2.1B
Gross Profit $852.5M $856.3M $629.5M $609.8M $637.2M
Gross Profit Margin 26.79% 25.59% 21.26% 21.24% 23%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $601.1M $603M $555M $547.5M $527.9M
Operating Income $251.5M $253.2M $74.5M $62.3M $109.3M
 
Net Interest Expenses $12.1M $10.8M $9.8M $9.4M $14.3M
EBT. Incl. Unusual Items $52.7M $131.8M $4.5M $38.7M $47.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $30.8M $24.4M $10.5M $13.9M $12.9M
Net Income to Company $52.7M $131.8M $4.5M $38.7M $47.1M
 
Minority Interest in Earnings $17.8M $7.2M $1.1M -$7.8M -$21M
Net Income to Common Excl Extra Items $39.6M $114.6M -$4.9M $17M $13.2M
 
Basic EPS (Cont. Ops) $0.45 $1.29 -$0.05 $0.19 $0.15
Diluted EPS (Cont. Ops) $0.45 $1.29 -$0.05 $0.19 $0.15
Weighted Average Basic Share $88.8M $88.9M $88.9M $88.1M $88.1M
Weighted Average Diluted Share $88.8M $88.9M $88.9M $88.1M $88.1M
 
EBITDA $244.9M $321.4M $155.4M $185.4M $210.4M
EBIT $64.8M $142.6M $14.4M $48.1M $61.4M
 
Revenue (Reported) $3.2B $3.3B $3B $2.9B $2.8B
Operating Income (Reported) $251.5M $253.2M $74.5M $62.3M $109.3M
Operating Income (Adjusted) $64.8M $142.6M $14.4M $48.1M $61.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $827M $797.7M $692.4M $730.8M $688.8M
Revenue Growth (YoY) 8.2% -3.55% -13.2% 5.55% -2.61%
 
Cost of Revenues $599.4M $599.3M $549.8M $574.9M $532.8M
Gross Profit $227.5M $198.4M $142.6M $155.9M $156.1M
Gross Profit Margin 27.52% 24.87% 20.6% 21.33% 22.66%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $152M $147.5M $130.7M $138.1M $134.8M
Operating Income $75.5M $50.9M $11.9M $17.8M $21.3M
 
Net Interest Expenses $3.1M $2.6M $2.4M $2.4M $4M
EBT. Incl. Unusual Items -$40M $31.4M -$4.3M $3.7M $12.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$574.5K $10M $4.7M $2.8M $3.8M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $14.4M -$88K $439.8K -$3.8M -$4.6M
Net Income to Common Excl Extra Items -$25.1M $21.3M -$8.6M -$3M $4M
 
Basic EPS (Cont. Ops) -$0.28 $0.24 -$0.10 -$0.03 $0.05
Diluted EPS (Cont. Ops) -$0.28 $0.24 -$0.10 -$0.03 $0.05
Weighted Average Basic Share $88.8M $88.9M $89M $88.1M $88.2M
Weighted Average Diluted Share $88.8M $88.9M $89M $88.1M $88.2M
 
EBITDA -$37M $33.9M -$1.9M $6.1M $16.4M
EBIT -$37M $33.9M -$1.9M $6.1M $16.4M
 
Revenue (Reported) $827M $797.7M $692.4M $730.8M $688.8M
Operating Income (Reported) $75.5M $50.9M $11.9M $17.8M $21.3M
Operating Income (Adjusted) -$37M $33.9M -$1.9M $6.1M $16.4M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3.2B $3.3B $3B $2.9B $2.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.3B $2.5B $2.3B $2.3B $2.2B
Gross Profit $853.1M $856.6M $630M $608.4M $644.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $601.1M $602.2M $555.1M $547.3M $534.3M
Operating Income $252M $254.5M $75M $61.1M $110.4M
 
Net Interest Expenses $12.1M $10.8M $9.8M $9.4M $14.5M
EBT. Incl. Unusual Items $51.8M $133.9M $5.2M $37.9M $47.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $30.7M $24.7M $10.6M $13.9M $12.9M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $18M $7M $1.1M -$7.3M -$21.3M
Net Income to Common Excl Extra Items $39M $116.1M -$4.3M $16.7M $13.2M
 
Basic EPS (Cont. Ops) $0.44 $1.31 -$0.05 $0.19 $0.15
Diluted EPS (Cont. Ops) $0.44 $1.31 -$0.05 $0.19 $0.15
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $63.9M $144.7M $15M $47.3M $212.7M
EBIT $63.9M $144.7M $15M $47.3M $61.9M
 
Revenue (Reported) $3.2B $3.3B $3B $2.9B $2.8B
Operating Income (Reported) $252M $254.5M $75M $61.1M $110.4M
Operating Income (Adjusted) $63.9M $144.7M $15M $47.3M $61.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $2.5B $2.2B $2.1B $1.4B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.8B $1.7B $1.7B $1.1B --
Gross Profit $649M $480.8M $451.9M $304.2M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $442.2M $409.5M $417.8M $263.1M --
Operating Income $206.8M $71.2M $34.1M $41.1M --
 
Net Interest Expenses $8.3M $7.4M $6.9M $6.8M --
EBT. Incl. Unusual Items $135.9M $108.3M $24.7M $25.7M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $26.6M $34.2M $13.4M $6.8M --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $468.5K $448K -$518.2K -$10M --
Net Income to Common Excl Extra Items $109.8M $74.6M $10.8M $9M --
 
Basic EPS (Cont. Ops) $1.24 $0.84 $0.12 $0.10 --
Diluted EPS (Cont. Ops) $1.24 $0.84 $0.12 $0.10 --
Weighted Average Basic Share $266.6M $266.8M $264.3M $176.3M --
Weighted Average Diluted Share $266.6M $266.8M $264.3M $176.3M --
 
EBITDA $144.2M $115.7M $31.6M $32.5M --
EBIT $144.2M $115.7M $31.6M $32.5M --
 
Revenue (Reported) $2.5B $2.2B $2.1B $1.4B --
Operating Income (Reported) $206.8M $71.2M $34.1M $41.1M --
Operating Income (Adjusted) $144.2M $115.7M $31.6M $32.5M --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $314.5M $222.7M $455.6M $223.3M $191M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $772.2M $746.2M $663.6M $579.7M $618.5M
Inventory $691.8M $786.9M $914.9M $805.9M $795.2M
Prepaid Expenses -- -- -- -- --
Other Current Assets $152.1M $201.4M $207.9M $198.7M $181.6M
Total Current Assets $1.9B $2B $2.2B $1.8B $1.8B
 
Property Plant And Equipment $2B $1.9B $1.8B $1.9B $2B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $42.4M $35.3M $34.8M $30.9M $33.6M
Other Long-Term Assets $62.7M $69.7M $65.5M $75.6M $71.5M
Total Assets $4.5B $4.2B $4.4B $4B $4.1B
 
Accounts Payable $370.6M $384.1M $401M $328.9M $323.4M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $226.6M $271.1M $249.3M $215.8M $180.1M
Total Current Liabilities $1.2B $1.2B $1.5B $1.2B $1.1B
 
Long-Term Debt $1.1B $1B $856.3M $962.2M $1.2B
Capital Leases -- -- -- -- --
Total Liabilities $2.7B $2.6B $2.8B $2.5B $2.6B
 
Common Stock $468.9M $423.8M $388.2M $341.8M $345.7M
Other Common Equity Adj -- -- -- -- --
Common Equity $1.7B $1.6B $1.4B $1.3B $1.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $26.3M $18.6M $238.9M $218.4M $245.5M
Total Equity $1.7B $1.6B $1.7B $1.5B $1.6B
 
Total Liabilities and Equity $4.5B $4.2B $4.4B $4B $4.1B
Cash and Short Terms $314.5M $222.7M $455.6M $223.3M $191M
Total Debt $1.7B $1.5B $1.7B $1.6B $1.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $314.5M $222.7M $455.6M $223.3M $191M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $772.2M $746.2M $663.6M $579.7M $618.5M
Inventory $691.8M $786.9M $914.9M $805.9M $795.2M
Prepaid Expenses -- -- -- -- --
Other Current Assets $152.1M $201.4M $207.9M $198.7M $181.6M
Total Current Assets $1.9B $2B $2.2B $1.8B $1.8B
 
Property Plant And Equipment $2B $1.9B $1.8B $1.9B $2B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $42.4M $35.3M $34.8M $30.9M $33.6M
Other Long-Term Assets $62.7M $69.7M $65.5M $75.6M $71.5M
Total Assets $4.5B $4.2B $4.4B $4B $4.1B
 
Accounts Payable $370.6M $384.1M $401M $328.9M $323.4M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $226.6M $271.1M $249.3M $215.8M $180.1M
Total Current Liabilities $1.2B $1.2B $1.5B $1.2B $1.1B
 
Long-Term Debt $1.1B $1B $856.3M $962.2M $1.2B
Capital Leases -- -- -- -- --
Total Liabilities $2.7B $2.6B $2.8B $2.5B $2.6B
 
Common Stock $468.9M $423.8M $388.2M $341.8M $345.7M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $26.3M $18.6M $238.9M $218.4M $245.5M
Total Equity $1.7B $1.6B $1.7B $1.5B $1.6B
 
Total Liabilities and Equity $4.5B $4.2B $4.4B $4B $4.1B
Cash and Short Terms $314.5M $222.7M $455.6M $223.3M $191M
Total Debt $1.7B $1.5B $1.7B $1.6B $1.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $52.7M $131.8M $4.5M $38.7M $47.1M
Depreciation & Amoritzation $180.1M $178.9M $141.1M $137.3M $149M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $2.9M -$61.2M $17.2M $415.8K -$29.4M
Change in Inventories $47.8M -$162.2M -$181.8M $14.1M $7.7M
Cash From Operations $330.4M $152.3M $57.7M $149.7M $197.7M
 
Capital Expenditures $259.4M $259.3M $290M $392.4M $296.9M
Cash Acquisitions -- -- $16.2M -- $12.8M
Cash From Investing -$298.8M -$219.2M -$266.7M -$407.4M -$304.5M
 
Dividends Paid (Ex Special Dividend) -$33.5M -$31.6M -$26.3M -$24.5M -$23.1M
Special Dividend Paid
Long-Term Debt Issued $113.2M $222.3M $319.1M $416.8M $377.5M
Long-Term Debt Repaid -$89.3M -$181.4M -$274.1M -$280.1M -$186M
Repurchase of Common Stock -$18.9K -$26.7K -$5.1M -$2.2M -$13.1K
Other Financing Activities -$8.1M -$8.2M $223.6M -$18.5M -$12.7M
Cash From Financing $50.4M -$15.4M $453.9M $57.2M $68.9M
 
Beginning Cash (CF) $236.6M $307.5M $195.8M $417.2M $218.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $82M -$82.3M $245M -$200.5M -$37.9M
Ending Cash (CF) $325.7M $235.5M $445.8M $230.8M $180.1M
 
Levered Free Cash Flow $71.1M -$107M -$232.2M -$242.8M -$99.2M
Period Ending 2007-03-31 2008-03-31 2009-03-31 2010-03-31 2011-03-31
Net Income to Stockholders -- -- -- $12.9M $4.1M
Depreciation & Amoritzation -- -- -- $39.5M $51.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$90.8M -$101.9M
Change in Inventories -- -- -- $28.6M $16.3M
Cash From Operations -- -- -- $75.7M $54.9M
 
Capital Expenditures -- -- -- $47.3M $46.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$23.6M -$32.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- $862.7K $1.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $155.9M $20.7M
Long-Term Debt Repaid -- -- -- -$109.6M -$46.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$199.3M $25.9M
Cash From Financing -- -- -- -$214.2M $89M
 
Beginning Cash (CF) -- -- -- $271.5M $148.2M
Foreign Exchange Rate Adjustment -- -- -- $1.3M -$157K
Additions / Reductions -- -- -- -$162.1M $111.5M
Ending Cash (CF) -- -- -- $107.3M $254.7M
 
Levered Free Cash Flow -- -- -- $28.4M $8.6M
Period Ending 2007-12-31 2008-12-31 2009-12-31 2010-12-31 2011-12-31
Net Income to Stockholders -- -- -- $66.7M --
Depreciation & Amoritzation -- -- -- $210M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- $13M --
Change in Inventories -- -- -- -$41.5M --
Cash From Operations -- -- -- $412.3M --
 
Capital Expenditures -- -- $108.2M $164.2M $46.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$125.6M --
 
Dividends Paid (Ex Special Dividend) -- -- -$27.2M -$30.6M $1.2M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $331.8M --
Long-Term Debt Repaid -- -- -- -$419.3M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$225.1M --
Cash From Financing -- -- -- -$418.3M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$131.6M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- $248.1M --
Period Ending 2021-05-21 2022-05-21 2023-05-21 2024-05-21
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
RGC alert for May 21

Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.

Buy
64
AKRO alert for May 21

Akero Therapeutics [AKRO] is up 24.59% over the past day.

Buy
76
AGYS alert for May 21

Agilysys [AGYS] is up 22.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock